|
Development of personalized surgical algorithms for muscle-invasive bladder cancer patients
|
5R21CA218976-02
|
$238,815
|
|
ABBOSH, PHILIP
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Detection of somatic, subclonal and mosaic CNVs from sequencing
|
1U24CA220242-01A1
|
$559,916
|
|
ABYZOV, ALEXEJ
|
MAYO CLINIC ROCHESTER
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
5R01CA140368-07
|
$369,313
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Analysis of HCC CTC Phenotype for Liver Transplant Candidate Selection
|
1R21CA216807-01A1
|
$203,254
|
|
AGOPIAN, VATCHE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Assessment of sensory gating, attention, and executive control in breast cancer
|
1R01CA218496-01A1
|
$687,576
|
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
|
5R01CA134633-06
|
$535,071
|
|
AHRENS, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Targeting transducin Beta-like protein 1 in mantle cell lymphoma
|
1K08CA226352-01
|
$227,046
|
|
ALINARI, LAPO
|
OHIO STATE UNIVERSITY
|
|
Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma
|
1R37CA225791-01
|
$358,389
|
|
ALJITAWI, OMAR
|
UNIVERSITY OF ROCHESTER
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-03
|
$520,564
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Cell-cell communications create robust collective immunological responses
|
ZIA BC 011728
|
$198,401
|
$49,600
|
Altan-Bonnet, Gregoire
|
CCR (NCI)
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
ZIA BC 010624
|
$149,910
|
$44,973
|
Ambs, Stefan
|
CCR (NCI)
|
|
Clinical trials in women's cancers
|
ZIA BC 011584
|
$192,282
|
$19,228
|
Annunziata, Christina
|
CCR (NCI)
|
|
Immune cell control of ovarian cancer
|
ZIA BC 011775
|
$288,423
|
$144,212
|
Annunziata, Christina
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-04
|
$604,525
|
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$298,466
|
$74,616
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
5R01CA210911-02
|
$348,844
|
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
The impact of e-cigarette use on adolescent uptake and persistence of conventional smoking: Who is most vulnerable?
|
5R01CA202262-03
|
$621,365
|
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain
|
5R01CA206058-03
|
$634,518
|
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-06
|
$660,173
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
|
1R37CA215427-01A1
|
$352,275
|
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
The contribution of the innate immune sensor STING in GVHD and GVL following allogeneic hematopoietic stem cell transplantation
|
1F31CA216999-01A1
|
$44,524
|
|
BADER, CAMERON
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design
|
1R01CA225615-01
|
$632,908
|
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
|
1R37CA226969-01
|
$355,706
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Development of a Total Nutrient Index
|
5U01CA215834-02
|
$348,136
|
|
BAILEY, REGAN
|
PURDUE UNIVERSITY
|
|
Normal and Neoplastic Growth in the Brain
|
5P01CA096832-14
|
$1,999,508
|
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
7T Neurosurgical Mapping Protocol for Endoscopic Resection of Skull Base Tumors
|
5R01CA202911-03
|
$387,731
|
|
BALCHANDANI, PRITI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Functional Significance of CD133 in Pancreatic Cancer
|
5R01CA184274-05
|
$318,513
|
|
BANERJEE, SULAGNA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam
|
5R01CA211150-02
|
$643,101
|
|
BANKSON, JAMES
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Fundamental subcortical mechanisms of affective processing
|
5U01CA193632-03
|
$350,973
|
|
BARRETT, LISA
|
NORTHEASTERN UNIVERSITY
|
|
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer
|
5U01CA200462-03
|
$910,580
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Annual International Primary CNS Lymphoma Collaborative Group Meeting
|
2R13CA124293-11
|
$5,000
|
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Pancreatic Cancer Metastasis
|
1P01CA217798-01A1
|
$1,643,391
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
MIC-1 and its functional partners in prostate cancer racial disparity
|
5U01CA185148-04
|
$312,080
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Real-time Tumor Localization and Guidance for Radiotherapy Using US and MRI
|
5R01CA190298-04
|
$418,528
|
|
BEDNARZ, BRYAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Dietary fats, mitochondrial function and muscle health in cancer patients
|
1R21CA209566-01A1
|
$199,655
|
|
BELURY, MARTHA
|
OHIO STATE UNIVERSITY
|
|
Genomics of HCC in the Hispanic population of Texas
|
1R01CA204665-01A1
|
$390,463
|
|
BERETTA, LAURA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Early Detection of Hepatocellular Carcinoma
|
5R01CA195524-03
|
$644,934
|
|
BERETTA, LAURA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Regulatory Impact on Vape Shops and Young Adults Use of ENDS
|
1R01CA215155-01A1
|
$659,909
|
|
BERG, CARLA
|
EMORY UNIVERSITY
|
|
Optimizing Tobacco Dependence Treatment in the Emergency Department
|
5R01CA201873-03
|
$730,670
|
|
BERNSTEIN, STEVEN
|
YALE UNIVERSITY
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
|
5P01CA206980-02
|
$2,361,160
|
|
BERWICK, MARIANNE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$3,223,418
|
$322,342
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Improving Routine Asymptomatic Cancer Screening among Federally Qualified Health Center Users in Florida: Application of a Health Literacy Framework
|
1K01CA226355-01
|
$149,430
|
|
BEST, ALICIA
|
UNIVERSITY OF SOUTH FLORIDA
|
|
G-CSF inhibition as a colorectal cancer therapy
|
7R01CA207051-03
|
$348,844
|
|
BESWICK, ELLEN
|
UNIVERSITY OF UTAH
|
|
Racism, Residential Racial Segregation, and Breast Cancer Survival Disparities among Black, Hispanic and non-Hispanic White Women
|
5R01CA214805-02
|
$455,960
|
|
BEYER, KIRSTEN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Epigenetic Age as a Marker of Reproductive Age and Modifier of Invasive Breast Cancer Risk Among Postmenopausal Women
|
1K07CA225856-01
|
$158,546
|
|
BINDER, ALEXANDRA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
|
1R21CA218973-01A1
|
$203,042
|
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia
|
1R37CA227656-01
|
$349,988
|
|
BLACKBURN, JESSICA
|
UNIVERSITY OF KENTUCKY
|
|
Breaking the paradigm: RhoA as a tumor suppressor in cancer
|
5F31CA216965-02
|
$30,558
|
|
BLAKE, DEVON
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
Total relevant funding to Interferon for this search: $4,714,209
|